The US regulator has approved a drug to treat low potassium as the first generic with the Competitive Generic Therapy (CGT) designation, marking the beginning of a new strategy and FDA effo
Cancer biosimilar drug Pelgraz is poised to hit the market after receiving a positive opinion by the Committee for Medicinal Products for Human Use (CHMP).
